Access BNP Clinical Enrollment Study

Beckman Coulter

Status

Completed

Conditions

Heart Failure

Treatments

Diagnostic Test: BNP

Study type

Observational

Funder types

Industry

Identifiers

NCT06624293

BNP-05-24

Details and patient eligibility

About

The goal of this study is to collect blood from subjects with a suspicion of either new onset or worsened heart failure to be used for testing studies for a new product to aid in the diagnosis of heart failure.

Enrollment

1,100 patients

Sex

All

Ages

22+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Ability to provide informed consent
Adult greater than or equal to 22 years old, any gender, race, ethnicity
Presenting with clinical suspicion of new onset heart failure or worsening symptoms suggestive of decompensated or exacerbated heart failure
Ability to fulfill study data collection requirements (including responding to questions for the NYHA evaluation)

Exclusion criteria

Individuals less than 22 years old
Impairment in individual's capacity to give informed consent
Dyspnea clearly not secondary to heart failure (e.g., primary lung disease or chest trauma).
On dialysis
On nesiritide infusion
Subject clinical/medical history access is not available to Sponsor, delegates, and FDA or other regulatory agencies upon request.
Active participation in a clinical study that may interfere with participation in this study (e.g., investigational drug study)
Reason(s) determined by the Principal Investigator that would place the individual at increased risk or preclude the individual from fully complying with or completing the study.